-

AXON ENTERPRISE, INC. INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 18.18% Share Drop

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Axon Enterprise, Inc. (“Axon” or the “Company”) (NASDAQ: AXON) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]

What Happened?

On November 5, 2026, Axon announced its third quarter 2026 financial results, reporting quarterly revenue of approximately $909 million, $25 million to $29 million below analyst consensus estimates of $934 million to $938 million, as well as earnings of $1.72 per share, short of the $1.88 to $1.91 analysts expected. The Company also disclosed that 3 Federal Dedrone deployments, representing $130 million of revenue and $200 million of bookings, would be delayed into 2027. Specifically, Axon announced that a $30 million Federal Dedrone deployment would be “moved out of Q3,” and that “our Q4 outlook no longer assumed 2 large Federal Dedrone deployments totaling approximately $100 million.” Axon President Joshua Isner stated, “We’re seeing some delays, and we can’t be sure those come through this year.” On this news, the price of Axon shares declined by $69.56 per share, or approximately 18.18%, from $382.56 per share on November 5, 2026 to close at $313.00 on November 6, 2026.

What Should I Do?

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.

If you purchased or otherwise acquired Axon securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found on Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP

NASDAQ:AXON

Release Versions
$Cashtags

Contacts

More News From Kirby McInerney LLP

KGC INVESTORS: Contact Kirby McInerney LLP About the Securities Fraud Lawsuit Filed on Behalf of Kinross Gold Corporation Shareholders

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds investors who purchased Kinross Gold Corporation (“Kinross” or the “Company”) (NYSE: KGC) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below by January 5, 2027, to discuss your rights or interests in the securities fraud class action at no cost. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Is The Lawsuit About? The lawsuit has been filed on behalf of invest...

OI Investors: O-I Glass, Inc. Shares Declined By $1.36 On July 29, 2026 ‒ Contact Kirby McInerney LLP to Discuss Your Rights

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your O-I Glass, Inc. (“O-I Glass” or the “Company”) (NYSE: OI) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until December 28, 2026 to ask the Court to appoint them as lead plaintiff.[CONTACT THE FIRM IF YOU SUFFERED A LOSS]What Is The Lawsuit Abo...

BIODESIX, INC. BDSX INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 57% Share Drop

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Biodesix, Inc. (“Biodesix” or the “Company”) (NASDAQ: BDSX) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]What Happened?On November 5, 2026, Biodesix announced its third quarter 2026 financial results, reporting third quarte...
Back to Newsroom